SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Don't Ask Rambi
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JF Quinnelly who wrote (50982)5/23/2000 2:19:00 PM
From: Ilaine  Read Replies (2) of 71178
 
Interesting article in today's Washington Post about the Human Genome Project - might be good for a few points on Celera or Incyte? But a careful reading reveals that after the human genome is finally sequenced, treatment breakthroughs are going to be slow. This week's Nature magazine has a five page fold-out illustration of the DNA sequence of human chromosome 21 (by far the smallest chromosome) - 127 known genes, 98 predicted genes, and 59 pseudogenes, whatever that is, but researchers only know what a fraction of the genes do. In case you're wondering, the authors of the Nature article all work for research centers like Institut fur Molekulare Biotechnologie, National Cancer Research Institute, University of Tokyo, University of London, etc. No hot stock tip there.

washingtonpost.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News